Research in Ovarian Cancer
The Blanton-Davis Ovarian Cancer Research Program was the nation’s first formal, comprehensive ovarian cancer research effort aimed at translating basic discoveries into improved therapies and management of the disease.
Today, the program continues to lead the nation in innovative research into the causes, prevention, detection and treatment of ovarian cancer.
Basic science and clinical research initiatives play a critical role in our mission to eradicate ovarian cancer. At MD Anderson, findings in the laboratory are quickly translated to the clinics, offering patients access to innovative new therapies and the opportunity to participate in clinical trials not available elsewhere. Support from major federal grants and private philanthropy have fueled this progress.